newsfilter
← Latest News
GlobeNewswire·

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States

COSM
  • Cosmos Health Inc. (NASDAQ: COSM) announced its entry into the global beauty & personal care market on June 17, 2026.
  • A premium, Korean-developed collagen-based skincare line has commenced sales in the United States via a direct-to-consumer model.
  • The company plans a multi-brand strategy to scale globally & deepen its presence in the high-growth skincare category.
  • This move diversifies the company toward higher-margin products & more lucrative end markets.
  • The global skincare market was valued at approximately $163 billion in 2026 & is projected to reach $203 billion by 2033.
  • CEO Greg Siokas stated the expansion is a natural extension of the strategy to grow through higher-margin categories.
  • Cosmos Health owns proprietary pharmaceutical & nutraceutical brands including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept®, & C-Scrub®.
  • Subsidiary Cana Laboratories S.A. manufactures pharmaceuticals, supplements, cosmetics, & medical devices within the European Union under EMA certification.
  • The company distributes pharmaceuticals & parapharmaceuticals to retail pharmacies & wholesale distributors through subsidiaries in Greece & the UK.
  • Cosmos Health has established R&D partnerships for obesity, diabetes, & cancer using AI drug repurposing technologies.
  • The company entered the telehealth space through the acquisition of ZipDoctor, Inc. based in Texas.
  • Forward-looking statements in the release involve risks regarding financing, digital asset strategies, geopolitical conflicts, & regulatory changes.